Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Madhav Dhodapkar"'
Autor:
Hans C. Lee, Naresh Bumma, Joshua Richter, Madhav Dhodapkar, James E. Hoffman, Attaya Suvannasankha, Jeffrey Zonder, Mansi R. Shah, Suzanne Lentzsch, Joseph J. Maly, Jing Christine Ye, Ka Lung Wu, Michelle Deveaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, Karen Rodriguez Lorenc, Glenn Kroog, Yariv Houvras, Sundar Jagannath
Publikováno v:
HemaSphere, Vol 7, p e1610068 (2023)
Externí odkaz:
https://doaj.org/article/ebffe14a73ae40d0a1f44b84269e2dd0
Autor:
Melissa Alsina, Madhav Dhodapkar, Jesus Berdeja, Krina Patel, Shambavi Richard, Ravi Vij, Xavier Leleu, Daniel Egan, P. Leif Bergsagel, Reshef Ran, Saad Z Usmani, Anna Truppel-Hartmann, Debashree Basudhar, Ethan Thompson, Xirong Zheng, Xiaobo Zhong, Chiara Greggio, Mihaela Popa Mckiver, Marlene Carrasco Alfonso, David Siegel
Publikováno v:
HemaSphere, Vol 7, p e90596a3 (2023)
Externí odkaz:
https://doaj.org/article/6236526bdbd74b7b92eb7a5ad306efce
Autor:
James L Gulley, James Larkin, Leisha A Emens, Mario Sznol, Madhav Dhodapkar, Daniel S Chen, Roy S Herbst, Tim F Greten, Robert L Ferris, Luca Mazzarella, Paolo A Ascierto, Marc S Ernstoff, Michael B Atkins, Kim A Margolin, Brian I Rini, Michael R Bishop, Suresh S Ramalingam, Meredith M Regan, Rachel W Humphrey
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 9 (2022)
The broad activity of agents blocking the programmed cell death protein 1 and its ligand (the PD-(L)1 axis) revolutionized oncology, offering long-term benefit to patients and even curative responses for tumors that were once associated with dismal p
Externí odkaz:
https://doaj.org/article/924c88f5ec8f4838a91c8255c8c43862
Autor:
Yanyan Gu, Benjamin G. Barwick, Mala Shanmugam, Craig C. Hofmeister, Jonathan Kaufman, Ajay Nooka, Vikas Gupta, Madhav Dhodapkar, Lawrence H. Boise, Sagar Lonial
Publikováno v:
Blood Cancer Journal, Vol 10, Iss 12, Pp 1-10 (2020)
Abstract Protein homeostasis is critical for maintaining eukaryotic cell function as well as responses to intrinsic and extrinsic stress. The proteasome is a major portion of the proteolytic machinery in mammalian cells and plays an important role in
Externí odkaz:
https://doaj.org/article/6ff11ca5684d40f9b59e2f4a4be3c0cb
Autor:
Mohammad Zaidi, Yuchen Zhang, Kavita Dhodapkar, Madhav Dhodapkar, Gregory Lesinski, Christina Wu, Rafi Ahmed, Cameron Herting, Deon Doxie, Michael Ware, Olatunji Alese, Mehmet Akce, Amanda Ruggieri, Juan Sarmiento, Shishir Maithel, Bassel El-rayes
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/e5af7df8035b4282b04525c6f3215556
Autor:
Nirali Shah, Lili Yang, Anju Singh, Kasia Bourcier, Antoni Ribas, Pawel Kalinski, Ke Liu, Phil Greenberg, Carl June, Marcela Maus, Steven Rosenberg, Madhav Dhodapkar, Irina Tiper, Chantale Bernatchez, Michael Hudecek, Stanley Riddell, Stephen Gottschalk, Crystal Mackall, Lisa Butterfield, Greg Delgoffe, Michael Nishimura, Terry Fry, Marc S. Ernstoff, Christopher Klebanoff, Elad Sharon, Malcolm Brenner, Cliona Rooney, Christine Brown, Marc S Ernstoff, Tonya Webb, Magdalena Thurin, Wendell Lim, David Stroncek, Catherine Bollard, Helen Chen, Cameron Turtle, Christian Hinrichs, Laura K Fogli, Rosemarie Aurigemma, Connie L Sommers, Steven Albelda, Renier Brentjens, Yvonne Chen, Laronna Colbert, Kenneth Cornetta, Jason Cristofaro, Thomas Finn, Laura K Fogli Hunter, Alyssa Galaro, Ananda Goldrath, Ray Harris, Lori Henderson, Yuxia Jia, Dan Kaufman, Bruce Levine, Lawrence Lum, Samantha Maragh, Alex Marson, Raj Puri, Jake Reder, Kole Roybal, Rachelle Salomon, Tal Salz, Barbra Sasu, Andrea Schietinger, Connie L. Sommers, Minkyung Song, Fyodor Urnov, Anthony Welch, Travis Young, Jason Yovandich
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Cell-based immunotherapies have had remarkable success in the clinic, specifically in the treatment of hematologic malignancies. However, these strategies have had limited efficacy in patients with solid tumors. To better understand the challenges in
Externí odkaz:
https://doaj.org/article/f4500c9773db47d7abfb74eccac2d857
Autor:
Mohammad Zaidi, Yuchen Zhang, Kavita Dhodapkar, Madhav Dhodapkar, Gregory Lesinski, Matthew Farren, Christina Wu, Rafi Ahmed, Cameron Herting, Deon Doxie, Michael Ware, Olatunji Alese, Walid Shaib, Mehmet Akce, Amanda Ruggieri, Juan Sarmiento, Shishir Maithel, Bassel El-rayes
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/bec310594f32496d883a30fa5029bf28
Autor:
Yi Lin, Madhav Dhodapkar, Aaron P Rapoport, Ajai Chari, Nina Shah, Jack Aiello, David E Avigan, Jesus G Berdeja, Ivan M Borrello, Adam D Cohen, Karthik Ganapathi, Lissa Gray, Damian Green, Amrita Krishnan, Elisabet Manasanch, Nikhil C Munshi, Ajay K Nooka, Eric L Smith, Ravi Vij
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Outcomes in multiple myeloma (MM) have improved dramatically in the last two decades with the advent of novel therapies including immunomodulatory agents (IMiDs), proteasome inhibitors and monoclonal antibodies. In recent years, immunotherapy for the
Externí odkaz:
https://doaj.org/article/cfade875c1d0413986d344c84a15d63a
Autor:
Andrew Branagan, Eamon Duffy, Terri Parker, Stuart Seropian, Connor Foster, Lin Zhang, Rakesh Verma, Geliang Gan, Daniel Zelterman, Debra Brandt, Jeremy Kortmansky, David Witt, Madhav Dhodapkar
Publikováno v:
Journal of Clinical and Translational Science, Vol 1, Pp 31-32 (2017)
OBJECTIVES/SPECIFIC AIMS: (1) Evaluate safety of a novel influenza vaccination strategy in patients with plasma cell disorders. (2) Measure laboratory-confirmed influenza infection rates following a novel influenza vaccination strategy in patients wi
Externí odkaz:
https://doaj.org/article/9ab9f7963f0043e69a2b2a59a49fbc6a
Autor:
Rashid Khan, Madhav Dhodapkar, Adam Rosenthal, Christoph Heuck, Xenofon Papanikolaou, Pingping Qu, Frits van Rhee, Maurizio Zangari, Yogesh Jethava, Joshua Epstein, Shmuel Yaccoby, Antje Hoering, John Crowley, Nathan Petty, Clyde Bailey, Gareth Morgan, Bart Barlogie
Publikováno v:
Haematologica, Vol 100, Iss 9 (2015)
Multiple myeloma is preceded by an asymptomatic phase, comprising monoclonal gammopathy of uncertain significance and smoldering myeloma. Compared to the former, smoldering myeloma has a higher and non-uniform rate of progression to clinical myeloma,
Externí odkaz:
https://doaj.org/article/9f1fc6f156b1496f9b93c34a929d8402